Patents by Inventor Angus G. Dalgleish

Angus G. Dalgleish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AGENT
    Publication number: 20160002320
    Abstract: Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions.
    Type: Application
    Filed: July 7, 2015
    Publication date: January 7, 2016
    Applicant: AIMSCO LIMITED
    Inventors: Angus G. Dalgleish, Martin Cadogan, Jonathan Heeney, Stanley D.T. White
  • Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy
    Patent number: 8715677
    Abstract: Methods of enhancing immune response to an immunogen in a subject are disclosed. Also disclosed are methods of reducing the sensitivity to an allergen in a subject. The methods comprise the administration of an immunomodulatory compound in specific dosing regimens that result in enhanced immune response or reduced sensitivity.
    Type: Grant
    Filed: August 31, 2006
    Date of Patent: May 6, 2014
    Assignee: Celgene Corporation
    Inventors: Justin B. Bartlett, George W. Muller, Peter H. Schafer, Christine Galustian, Angus G. Dalgleish, Brendan Meyer
  • THERAPEUTIC AGENT
    Publication number: 20130230600
    Abstract: Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions.
    Type: Application
    Filed: February 8, 2013
    Publication date: September 5, 2013
    Applicant: AIMSCO LIMITED
    Inventors: Angus G. Dalgleish, Martin Cadogan, Jonathan Heeney, Stanley D.T. White
  • IMMUNOLOGICAL USES OF IMMUNOMODULATORY COMPOUNDS FOR VACCINE AND ANTI-INFECTIOUS DISEASE THERAPY
    Publication number: 20120190110
    Abstract: Methods of enhancing immune response to an immunogen in a subject are disclosed. Also disclosed are methods of reducing the sensitivity to an allergen in a subject. The methods comprise the administration of an immunomodulatory compound in specific dosing regimens that result in enhanced immune response or reduced sensitivity.
    Type: Application
    Filed: April 2, 2012
    Publication date: July 26, 2012
    Inventors: Justin B. BARTLETT, George W. Muller, Peter H. Schafer, Christine Galustian, Angus G. Dalgleish, Brendan Meyer
  • Therapeutic Agent
    Publication number: 20120100156
    Abstract: Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions.
    Type: Application
    Filed: December 9, 2011
    Publication date: April 26, 2012
    Inventors: Angus G. Dalgleish, Martin Cadogan, Jonathan Heeney, Stanley D. T. White
  • Treatment of MS with goat serum
    Publication number: 20110086046
    Abstract: A serum composition from a goat immunised with HIV contains anti-HLA antibody and is suited for palliative improvement of the condition of an animal.
    Type: Application
    Filed: January 28, 2003
    Publication date: April 14, 2011
    Inventors: Jonathan Heeney, Angus G. Dalgleish, Stanley D.T. White
  • Therapeutic Agent
    Publication number: 20100291102
    Abstract: Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions.
    Type: Application
    Filed: July 2, 2002
    Publication date: November 18, 2010
    Applicant: ICE BIOLOGICS LIMITED
    Inventors: Angus G. Dalgleish, Martin Cadogan, Jonathan Heeney, Stanley D.T. White